HRC Fire Inc

Evoia Inc is a Ventura-based company that specializes in bringing sustainable and environmentally friendly solutions to production agriculture through the use of fire. Their patented technology converts raw biomass into highly active biostimulants, resulting in consistent and beneficial compounds for plants. With a focus on climate-smart agriculture, Evoia Inc aims to be an innovative leader in the industry, helping growers improve their agroecosystems while reducing resource usage and achieving net-zero emissions. Their mission is to bring sustainable value to their partners' products, offering simple solutions inspired by nature.Generated from the website

Hi-Temp Insulation provides a range of metal foil, soft goods and sewn insulation designs to the aircraft, missile and space industries. The company s products are used in various thermal and acoustical applications. It operates a more than 100,000-square-foot facility that features a storage space and testing laboratories. The company also maintains rigidizing rollers, heated-platen presses, seam and spot welders, and sewing and heat-sealing machines. It has high-temperature ovens that help in shaping resin-impregnated fabrics. In addition, the company offers customer care and research and development services. It operates an engineering facility that provides quality control services. Hi-Temp Insulation s product list includes space, soft-flex and thrust-reverse blankets.

Acelot, Inc., based in Santa Barbara, CA, pioneers a new approach to developing small molecules for challenging targets in diseases with high unmet needs. The company's lead program focuses on targeting TDP-43 to treat amyotrophic lateral sclerosis (ALS), a neurodegenerative disease. TDP-43, a critical protein in cellular activities, plays a significant role in ALS progression by leading to the death of motor neurons. ACE-2223, Acelot's small molecule, is specifically designed to target misfolded forms of TDP-43 that contribute to ALS pathology. By disrupting the diseased form of TDP-43, the drug aims to restore the protein's healthy form and function, ultimately improving cellular health and motor neuron survival. Acelot's innovative approach includes de novo drug design and leveraging AI tools to create promising solutions for devastating diseases. The company's team comprises experts in rigorous science and efficient development, collaborating with renowned scientists to accelerate the delivery of potential treatment options. Acelot's pursuit extends beyond ALS, exploring applications in various neurodegenerative diseases like fronto-temporal dementia, Alzheimer's disease, and others. With a focus on cutting-edge research and drug development, Acelot strives to make a meaningful impact in the field of neurodegenerative diseases. Generated from the website content